Sitryx

Sitryx is a biopharmaceutical company focused on modulating cellular metabolism to develop first-in-class disease-modifying therapies in immuno-oncology and immune-inflammatory conditions. The company was co-founded by a world-leading team of scientists from the United States and Europe who have made significant contributions to the field of immunometabolism.